Covered recipient · General Payments record
CHRISTOPHER J GARRISON
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2023–2024
$465.52
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $449.20 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $220.60 | 7 |
| Abbott Laboratories | $135.45 | 1 |
| ABBVIE INC. | $49.51 | 2 |
| Avanos Medical | $23.10 | 1 |
| Merz Pharmaceuticals, LLC | $20.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $135.45 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125057945 | CMS |
| ABBVIE INC. | $22.70 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103778435 | CMS |
| ABBVIE INC. | $26.81 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103778437 | CMS |
| Avanos Medical | $23.10 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149305759 | CMS |
| Averitas Pharma Inc. | $28.20 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426777 | CMS |
| Averitas Pharma Inc. | $31.66 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426780 | CMS |
| Averitas Pharma Inc. | $33.50 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426785 | CMS |
| Averitas Pharma Inc. | $38.45 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426789 | CMS |
| Averitas Pharma Inc. | $29.63 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426793 | CMS |
| Averitas Pharma Inc. | $28.66 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426797 | CMS |
| Averitas Pharma Inc. | $30.50 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133426801 | CMS |
| Merz Pharmaceuticals, LLC | $20.54 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137947824 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.